Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 55
Recruiting: 38
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06445257	A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL	unknown	N/A	30	Huai'an First People's HospitalOTHER	1	Jun 6, 2024	clinicaltrials
NCT04845139	A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma	unknown	N/A	1	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Jul 7, 2022